Information  X 
Enter a valid email address

ClearStar,Inc. (CLSU)

  Print      Mail a friend

Tuesday 16 July, 2019

ClearStar,Inc.

Todd Shoulberg promoted to President, MIS

RNS Number : 6065F
ClearStar,Inc.
16 July 2019
 

16 July 2019

 

ClearStar, Inc.

("ClearStar" or the "Company")

 

ClearStar promotes Todd Shoulberg to President, Medical Information Services

 

ClearStar (AIM: CLSU), a provider of Human Capital Integritytechnology-based services specialising in background and medical screening, is pleased to announce that Todd Shoulberg has been promoted to President, Medical Information Services, with immediate effect.

 

Since joining ClearStar in 2007 as Executive Vice President, Medical Information Services ("MIS"), Todd has been instrumental in the growth of this business. Over the last five years, MIS revenue has increased over 110% to $8.3 million in 2018, accounting for 41% of total sales. In the first half of 2019, sales in MIS were 25% higher than in H1 2018. ClearStar has continually expanded and enhanced its MIS offer - from drug screening to clinical testing and occupational health, and developing its differentiated ClearMD mobile solution that greatly facilitates the test ordering and review process for employees. ClearStar has achieved integrations with all three major laboratories in the US so employees can use ClearMD with over 9,500 test locations, and the Company has established a total network of more than 18,000 medical test sites. This momentum is expected to continue with MIS remaining ClearStar's primary growth driver by service offering.

 

Robert Vale, CEO of ClearStar, said: "The expansion of our medical screening business has been fundamental to ClearStar's growth and continues to be our key driver by service offering. Todd has been instrumental to this success and we're delighted to promote him to President of Medical Information Services. His skills and expertise, supported by his talented team, have contributed to the solid execution of our strategies to grow our MIS sales. As we continue to invest in advancing our technologically-differentiated solutions, and broaden our reach into new markets, we look forward to reporting further progress."

 

In his role as President, Todd will continue to provide direction and leadership of the MIS business and daily operations of ClearStar's Medical Review Office, which implements independent and expert scrutiny of laboratory results under medical confidentiality. He is also responsible for ensuring that drug testing is conducted in compliance with state, federal and local regulations.

 

 

Enquiries:

 

ClearStar, Inc.

+1 877 796 2559

Robert Vale, Chief Executive Officer

Jennifer Balleza, Chief Financial Officer

 

 

 

finnCap Ltd.

+44 20 7220 0500

Jonny Franklin-Adams, Marc Milmo, Simon Hicks - Corporate Finance

Andrew Burdis - ECM

 

 

 

Luther Pendragon Ltd.

+44 20 7618 9100

Harry Chathli, Claire Norbury, Joe Quinlan

 

 

 

About ClearStar

 

ClearStar, Inc. is a leading provider of Human Capital Integrity℠ technology-based services specialising in background and medical screening. It provides employment intelligence direct to employers and via channel partners/consumer reporting agencies ("CRAs") to support better recruitment and other decisions affecting employees by increasing the quality, reliability and visibility of information.

 

A seven-time Inc. 5000 honouree and founding member of the National Association of Professional Background Screeners, ClearStar has provided innovative technology solutions to businesses in the human capital management industry from its corporate offices in Alpharetta, Georgia since 1995. For more information about ClearStar, please visit: www.clearstar.net

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NRABELLFKDFBBBB

a d v e r t i s e m e n t